levofloxacin

Experimental Therapeutics
Efficacy of High Doses of Levofloxacin in Experimental Foreign-Body Infection by Methicillin-Susceptible Staphylococcus aureus
O. Murillo, A. Doménech, A. Garcia, F. Tubau, C. Cabellos, F. Gudiol, J. Ariza
Clinical Therapeutics
Urinary Bactericidal Activity of Extended-Release Ciprofloxacin (1,000 Milligrams) versus Levofloxacin (500 Milligrams) in Healthy Volunteers Receiving a Single Oral Dose
Florian M. E. Wagenlehner, Martina Kinzig-Schippers, Uwe Tischmeyer, Christine Wagenlehner, Fritz Sörgel, Kurt G. Naber
Experimental Therapeutics
Pharmacokinetic Considerations and Efficacy of Levofloxacin in an Inhalational Anthrax (Postexposure) Rhesus Monkey Model
L. Mark Kao, Karen Bush, Roy Barnewall, James Estep, Frederic W. Thalacker, Pamela H. Olson, George L. Drusano, Neil Minton, Shuchean Chien, Alex Hemeryck, Michael F. Kelley
Susceptibility
Differential Effects of Levofloxacin and Ciprofloxacin on the Risk for Isolation of Quinolone-Resistant Pseudomonas aeruginosa
Keith S. Kaye, Zeina A. Kanafani, Ashley E. Dodds, John J. Engemann, Stephen G. Weber, Yehuda Carmeli
Pharmacology
Levofloxacin Pharmacokinetics and Pharmacodynamics in Patients with Severe Burn Injury
Tyree H. Kiser, Dorie W. Hoody, Marilee D. Obritsch, Colleen O. Wegzyn, Paulus C. Bauling, Douglas N. Fish
Experimental Therapeutics
Pharmacodynamics of Levofloxacin against Pseudomonas aeruginosa with Reduced Susceptibility Due to Different Efflux Pumps: Do Elevated MICs Always Predict Reduced In Vivo Efficacy?
David C. Griffith, Erik Corcoran, Denene Lofland, Angela Lee, Deidre Cho, Olga Lomovskaya, Michael N. Dudley
Mechanisms of Resistance
Prevalence of First-Step Mutants among Levofloxacin-Susceptible Invasive Isolates of Streptococcus pneumoniae in the United States
Mathias W. R. Pletz, Ardaman P. Shergill, Lesley McGee, Bernard Beall, Cynthia G. Whitney, Keith P. Klugman
and for the Active Bacterial Core Surveillance Team
Erratum
Levofloxacin and Moxifloxacin Increase Human Gut Colonization by Candida Species
LETTERS TO THE EDITOR
Levofloxacin and Moxifloxacin Increase Human Gut Colonization by Candida Species
George Samonis, Diamantis P. Kofteridis, Sofia Maraki, Dimitrios Alegakis, Elpis Mantadakis, John A. Papadakis, Achilleas H. Gikas, Matthew Falagas
Experimental Therapeutics
Effective Antimicrobial Regimens for Use in Humans for Therapy of Bacillus anthracis Infections and Postexposure Prophylaxis
Mark R. Deziel, Henry Heine, Arnold Louie, Mark Kao, William R. Byrne, Jennifer Basset, Lynda Miller, Karen Bush, Michael Kelly, G. L. Drusano

Main menu

User menu

Search

levofloxacin

Pages